Post-allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Changes in Inorganic Salivary Components

Overview

Journal Support Care Cancer

Specialties Critical Care
Oncology

Date 2015 Feb 6

PMID 25652148

Citations 9

Authors

C C Boer

M E P Correa

L M A Tenuta

C A Souza

A C Vigorito

Affiliations

Soon will be listed here.

Abstract

Recent studies have considered the qualitative and quantitative assessment of salivary flow, as well the biochemical components of saliva, as possible biomarkers that might contribute to the pathogenesis of chronic graft-versus-host disease (cGHVD) in hematopoietic stem cell transplantation (HSCT) patients. The aim of this study was to evaluate prospectively the inorganic salivary status at different periods of allogeneic HSCT. Saliva collection and oral examination were performed prior to the HSCT, between days 8 and 10, days 80 and 100, and at the cGVHD onset. Concentrations of calcium (Ca), phosphate (Pi), chloride (Cl), magnesium (Mg), potassium (K), and sodium (Na) were performed using colorimetric reactions and atomic absorption. Fifty-five consecutive patients undergoing first allogeneic HSCT were included in this study. Between days 8 and 10, the salivary flow rate was significantly higher (p = 0.05), Pi concentration was decreased (p = 0.007), and Na and Cl were increased (p = 0.001 and p = 0.001, respectively), compared with the baseline. Salivary flow rate during the same period showed a negative correlation with Pi concentration (p = 0.02) and a positive correlation with Na and Cl concentrations (p = 0.003 and p = 0.001, respectively). The salivary flow rate was decreased between days 80 and 100 (p = 0.02) and Na, Cl, and K concentrations were increased (p = 0.03, p = 0.02, and p = 0.003, respectively). Salivary flow rate showed a negative correlation with Na and Cl (p = 0.01 and p = 0.013, respectively). At cGVHD onset, the salivary flow rate showed no statistical difference compared with the other studied periods. A trend was observed in the higher Na concentration compared with the baseline (p = 0.06) and Pi concentration presented a significant decrease (p = 0.004). Ca and Mg concentrations showed no changes during all evaluation periods. The present study showed changes in inorganic salivary components in post-HSCT periods, mainly during the early period post-HSCT and at the cGVHD onset. We speculate that Na, Cl, and Pi in saliva could be used as a potential biomarker in further studies.

Citing Articles

Salivary flow rate, subjective oral dryness and dental caries 5 years after haematopoietic cell transplantation.

Bulthuis M, van Gennip L, Thomas R, van Leeuwen S, Bronkhorst E, Laheij A BMC Oral Health. 2024; 24(1):1058.

PMID: 39256697 PMC: 11389434. DOI: 10.1186/s12903-024-04804-7.

Assessment of the Salivary Concentrations of Selected Immunological Components in Adult Patients in the Late Period after Allogeneic Hematopoietic Stem Cell Transplantation-A Translational Study.

Brodzikowska A, Kochanska B, Boguslawska-Kapala A, Struzycka I, Gorski B, Miskiewicz A Int J Mol Sci. 2024; 25(3).

PMID: 38338734 PMC: 10855433. DOI: 10.3390/ijms25031457.

The effect of conditioning regimen and prescribed medications on hyposalivation in haematopoietic cell transplantation (HCT) patients: an 18-month prospective longitudinal study.

Bulthuis M, van Gennip L, Thomas R, Bronkhorst E, Laheij A, Raber-Durlacher J Clin Oral Investig. 2023; 27(12):7369-7381.

PMID: 37853264 PMC: 10713764. DOI: 10.1007/s00784-023-05327-1.

Perspectives on oral chronic graft-versus-host disease from immunobiology to morbid diagnoses.

Tollemar V, Legert K, Sugars R Front Immunol. 2023; 14:1151493.

PMID: 37449200 PMC: 10338056. DOI: 10.3389/fimmu.2023.1151493.

Dental consensus on HSCT - Part II: dental Care during HSCT.

Gobbi M, Ferreira M, de Carvalho D, Silva G, Macari K, Neves L Hematol Transfus Cell Ther. 2023; 45(3):368-378.

PMID: 37321878 PMC: 10499574. DOI: 10.1016/j.htct.2023.04.003.

References

Horn T, Rest E, Mirenski Y, Corio R, Zahurak M, Vogelsang G . The significance of oral mucosal and salivary gland pathology after allogeneic bone marrow transplantation. Arch Dermatol. 1995; 131(8):964-5. DOI: 10.1001/archderm.131.8.964. View

Yamagata K, Arai C, Sasaki H, Takeuchi Y, Onizawa K, Yanagawa T . The effect of oral management on the severity of oral mucositis during hematopoietic SCT. Bone Marrow Transplant. 2011; 47(5):725-30. DOI: 10.1038/bmt.2011.171. View

Izutsu K, Sullivan K, Schubert M, Truelove E, Shulman H, Sale G . Disordered salivary immunoglobulin secretion and sodium transport in human chronic graft-versus-host disease. Transplantation. 1983; 35(5):441-6. DOI: 10.1097/00007890-198305000-00010. View

Imanguli M, Pavletic S, Guadagnini J, Brahim J, Atkinson J . Chronic graft versus host disease of oral mucosa: review of available therapies. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006; 101(2):175-83. DOI: 10.1016/j.tripleo.2005.08.028. View

Sonis S, Oster G, Fuchs H, Bellm L, BRADFORD W, Edelsberg J . Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation. J Clin Oncol. 2001; 19(8):2201-5. DOI: 10.1200/JCO.2001.19.8.2201. View

SILNESS J, Loe H . PERIODONTAL DISEASE IN PREGNANCY. II. CORRELATION BETWEEN ORAL HYGIENE AND PERIODONTAL CONDTION. Acta Odontol Scand. 1964; 22:121-35. DOI: 10.3109/00016356408993968. View

Schubert M, Correa M . Oral graft-versus-host disease. Dent Clin North Am. 2007; 52(1):79-109, viii-ix. DOI: 10.1016/j.cden.2007.10.004. View

Dens F, Boogaerts M, Boute P, Declerck D, Demuynck H, Vinckier F . Quantitative determination of immunological components of salivary gland secretion in transplant recipients. Bone Marrow Transplant. 1996; 17(3):421-3. View

Chaushu G, Yefenof E, Slavin S, Or R, Garfunkel A . A longitudinal follow-up of salivary secretion in bone marrow transplant patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995; 79(2):164-9. DOI: 10.1016/s1079-2104(05)80276-8. View

10.

Nagler R, Nagler A . The molecular basis of salivary gland involvement in graft--vs.--host disease. J Dent Res. 2004; 83(2):98-103. DOI: 10.1177/154405910408300203. View

11.

Tanaka M . Secretory function of the salivary gland in patients with taste disorders or xerostomia: correlation with zinc deficiency. Acta Otolaryngol Suppl. 2002; (546):134-41. DOI: 10.1080/00016480260046526. View

12.

Filipovich A, Weisdorf D, Pavletic S, Socie G, Wingard J, Lee S . National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant. 2005; 11(12):945-56. DOI: 10.1016/j.bbmt.2005.09.004. View

13.

Gandara B, Izutsu K, Truelove E, MANDEL I, Sommers E, Ensign W . Sialochemistry of whole, parotid, and labial minor gland saliva in patients with oral lichen planus. J Dent Res. 1987; 66(11):1619-22. DOI: 10.1177/00220345870660110201. View

14.

Hiroki A, Nakamura S, Shinohara M, Gondo H, Ohyama Y, Hayashi S . A comparison of glandular involvement between chronic graft-versus-host disease and Sjögren's syndrome. Int J Oral Maxillofac Surg. 1996; 25(4):298-307. DOI: 10.1016/s0901-5027(06)80062-7. View

15.

SREEBNY L, Valdini A . Xerostomia. Part I: Relationship to other oral symptoms and salivary gland hypofunction. Oral Surg Oral Med Oral Pathol. 1988; 66(4):451-8. DOI: 10.1016/0030-4220(88)90268-x. View

16.

Tenuta L, Del Bel Cury A, Bortolin M, Vogel G, Cury J . Ca, Pi, and F in the fluid of biofilm formed under sucrose. J Dent Res. 2006; 85(9):834-8. DOI: 10.1177/154405910608500911. View

17.

Humphrey S, Williamson R . A review of saliva: normal composition, flow, and function. J Prosthet Dent. 2001; 85(2):162-9. DOI: 10.1067/mpr.2001.113778. View

18.

Dawes C . The effects of flow rate and duration of stimulation on the concentrations of protein and the main electrolytes in human submandibular saliva. Arch Oral Biol. 1974; 19(10):887-95. DOI: 10.1016/0003-9969(74)90051-x. View

19.

Soares A, Faria P, Magna L, Correa M, de Sousa C, Almeida O . Chronic GVHD in minor salivary glands and oral mucosa: histopathological and immunohistochemical evaluation of 25 patients. J Oral Pathol Med. 2005; 34(6):368-73. DOI: 10.1111/j.1600-0714.2005.00322.x. View

20.

Petersen P . The World Oral Health Report 2003: continuous improvement of oral health in the 21st century--the approach of the WHO Global Oral Health Programme. Community Dent Oral Epidemiol. 2004; 31 Suppl 1:3-23. DOI: 10.1046/j..2003.com122.x. View